These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31401672)

  • 1. Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
    Seitz A; Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; May AE; Empen K; Chorianopoulos E; Ritter B; Pirr J; Arseniev L; Heuft HG; Ganser A; Abu-Zaid E; Katus HA; Felix SB; Gawaz MP; Schultheiss HP; Ladage D; Bauersachs J; Mahrholdt H; Greulich S
    Clin Res Cardiol; 2020 May; 109(5):539-548. PubMed ID: 31401672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; Bonarjee V; Larsen AI; May AE; Empen K; Chorianopoulos E; Tebbe U; Waltenberger J; Mahrholdt H; Ritter B; Pirr J; Fischer D; Korf-Klingebiel M; Arseniev L; Heuft HG; Brinchmann JE; Messinger D; Hertenstein B; Ganser A; Katus HA; Felix SB; Gawaz MP; Dickstein K; Schultheiss HP; Ladage D; Greulich S; Bauersachs J
    Eur Heart J; 2017 Oct; 38(39):2936-2943. PubMed ID: 28431003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.
    Nicolau JC; Furtado RHM; Silva SA; Rochitte CE; Rassi A; Moraes JBMC; Quintella E; Costantini CR; Korman APM; Mattos MA; Castello HJ; Caixeta A; Dohmann HFR; de Carvalho ACC;
    Clin Cardiol; 2018 Mar; 41(3):392-399. PubMed ID: 29569254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy.
    Miettinen JA; Ylitalo K; Hedberg P; Jokelainen J; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
    Heart; 2010 Mar; 96(5):362-7. PubMed ID: 19910293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial.
    Garcia-Dorado D; García-del-Blanco B; Otaegui I; Rodríguez-Palomares J; Pineda V; Gimeno F; Ruiz-Salmerón R; Elizaga J; Evangelista A; Fernandez-Avilés F; San-Román A; Ferreira-González I
    Int J Cardiol; 2014 Dec; 177(3):935-41. PubMed ID: 25449504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.
    Meyer GP; Wollert KC; Lotz J; Pirr J; Rager U; Lippolt P; Hahn A; Fichtner S; Schaefer A; Arseniev L; Ganser A; Drexler H
    Eur Heart J; 2009 Dec; 30(24):2978-84. PubMed ID: 19773226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance.
    Bulluck H; Go YY; Crimi G; Ludman AJ; Rosmini S; Abdel-Gadir A; Bhuva AN; Treibel TA; Fontana M; Pica S; Raineri C; Sirker A; Herrey AS; Manisty C; Groves A; Moon JC; Hausenloy DJ
    J Cardiovasc Magn Reson; 2017 Mar; 19(1):26. PubMed ID: 28285594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
    Delewi R; Hirsch A; Tijssen JG; Schächinger V; Wojakowski W; Roncalli J; Aakhus S; Erbs S; Assmus B; Tendera M; Goekmen Turan R; Corti R; Henry T; Lemarchand P; Lunde K; Cao F; Huikuri HV; Sürder D; Simari RD; Janssens S; Wollert KC; Plewka M; Grajek S; Traverse JH; Zijlstra F; Piek JJ
    Eur Heart J; 2014 Apr; 35(15):989-98. PubMed ID: 24026778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global longitudinal strain by feature tracking for optimized prediction of adverse remodeling after ST-elevation myocardial infarction.
    Reindl M; Tiller C; Holzknecht M; Lechner I; Eisner D; Riepl L; Pamminger M; Henninger B; Mayr A; Schwaiger JP; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Clin Res Cardiol; 2021 Jan; 110(1):61-71. PubMed ID: 32296969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial.
    Schaefer A; Meyer GP; Fuchs M; Klein G; Kaplan M; Wollert KC; Drexler H
    Eur Heart J; 2006 Apr; 27(8):929-35. PubMed ID: 16510465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Chugh A; Yang PC; Zhao DXM; Ellis SG; Forder JR; Perin EC; Penn MS; Hatzopoulos AK; Chambers JC; Baran KW; Raveendran G; Gee AP; Taylor DA; Moyé L; Ebert RF; Simari RD
    Circ Res; 2018 Feb; 122(3):479-488. PubMed ID: 29208679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
    Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.
    Musialek P; Tekieli L; Kostkiewicz M; Miszalski-Jamka T; Klimeczek P; Mazur W; Szot W; Majka M; Banys RP; Jarocha D; Walter Z; Krupinski M; Pieniazek P; Olszowska M; Zmudka K; Pasowicz M; Kereiakes DJ; Tracz W; Podolec P; Wojakowski W
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):320-8. PubMed ID: 23271789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.
    Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD
    J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings.
    Bethke A; Shanmuganathan L; Andersen GØ; Eritsland J; Swanson D; Kløw NE; Hoffmann P
    Eur Radiol; 2019 Feb; 29(2):941-950. PubMed ID: 29980929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.